Clinic-Wide Intervention for Colorectal Cancer
Trial Summary
What is the purpose of this trial?
This clinical trial evaluates a clinic-wide intervention called Primary Care-Gastrointestinal (GI) Connect for improving follow-up colonoscopy rates in patients at a Federally Qualified Health Center (FQHC) who have an abnormal fecal immunochemical test (FIT) result. Colorectal cancer screening reduces colorectal cancer incidence and mortality but is underutilized.The most accessible, feasible, and common colorectal cancer screening modality for average-risk individuals in low resource settings such as FQHCs is the stool-based FIT. However, the benefit of FIT screening on colorectal cancer risk is realized only if individuals with abnormal FIT results undergo timely follow-up colonoscopy. Follow-up colonoscopy rates are low and there are many barriers to follow-up colonoscopy in safety net settings such as FQHCs. Effective interventions that are multi-component and improve care coordination are needed to improve abnormal FIT follow-up rates in FQHCs. The Primary Care-GI Connect intervention includes components that enhance care coordination, standardize the referral process, and engage both primary care and specialist physicians. This clinic-wide intervention may improve rates of follow-up colonoscopy after abnormal FIT results in patients seen at FQHCs.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Primary Care-GI Connect for colorectal cancer?
Research shows that primary care can improve colorectal cancer outcomes by increasing screening rates and early diagnosis, which are crucial for better survival. Additionally, interventions in primary care settings, like physician recommendations and providing test kits, have been effective in increasing screening completion.12345
How is the Primary Care-GI Connect treatment for colorectal cancer different from other treatments?
The Primary Care-GI Connect treatment is unique because it focuses on improving colorectal cancer screening rates through a clinic-wide intervention in primary care settings, rather than directly treating the cancer itself. This approach emphasizes increasing early detection and prevention by enhancing the collaboration between primary care and gastrointestinal specialists.678910
Research Team
Folasade P. May
Principal Investigator
UCLA / Jonsson Comprehensive Cancer Center
Eligibility Criteria
This trial is for patients at Federally Qualified Health Centers with abnormal fecal immunochemical test results, indicating potential colorectal cancer. It aims to improve follow-up colonoscopy rates, which are crucial for early detection and treatment.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention Implementation
Implementation of the Primary Care-GI Connect intervention to improve follow-up colonoscopy rates after abnormal FIT results
Follow-up
Participants are monitored for completion of colonoscopy and receipt of pathology results
Treatment Details
Interventions
- Primary Care-GI Connect
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jonsson Comprehensive Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator